Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study
International Journal of Epidemiology · 11.06.2025 · 54 (4)
DOI: 10.1093/ije/dyaf137 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Epidemiology, online erschienen am 06.08.2025. Verfasst von Jonathan Brett und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, St Vincent's Clinical School, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Analgesics, Opioid, Abruptio Placentae, Premature Birth, Pre-Eclampsia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Centre of Research Excellence in Medications Intelligence.
Abstract (Originalsprache)
Background
Analgesic opioid use in pregnancy could increase the risk of disorders related to placental malperfusion, but this relationship is incompletely characterized. We aimed to study the causal association between analgesic opioids in pregnancy and placental abruption, pre-eclampsia, preterm birth, and fetal growth restriction (FGR).
Methods
We conducted a population-based cohort study of pregnancies resulting in birth at ≥20 weeks of gestation between July 2013 and December 2019 in New South Wales, Australia. Linked data on pregnancy, births, medication dispensation, and health services were used. Opioid exposure was defined as at least one opioid dispensation from the last menstrual period to birth. We stratified analyses by exposure in early (≤20 weeks) and/or late (>20 weeks) pregnancy and opioid type by using non-exposed pregnancies as a comparator. We estimated risks by using Cox proportional-hazards models and time-varying exposure, adjusting for demographics, comorbidities, and other medications.
Results
Among 509 971 births, 32 266 (6.3%) had an opioid dispensation. We observed modestly increased risks with any opioid exposure for placental abruption [adjusted hazard ratio (HR) 1.22, 95% confidence interval (CI) 1.06–1.41] and preterm birth (adjusted HR 1.23, 95% CI 1.18–1.28), but not for pre-eclampsia (adjusted HR 1.06, 95% CI 0.99–1.13) or FGR (adjusted HR 0.95, 95% CI 0.88–1.02). Risks of abruption were the most elevated when exposure occurred in both early and late pregnancy (adjusted HR 1.76, 95% CI 1.30–2.40) and for preterm birth when exposure occurred in late-only pregnancy (adjusted HR 1.36, 95% CI 1.27–1.45). Monotherapy with both codeine and oxycodone was associated with elevated risks of abruption and preterm birth.
Conclusion
In this population-based cohort study, we observed modestly increased risks of preterm birth and placental abruption after analgesic opioid use in pregnancy, driven by codeine and oxycodone—the two most frequently used opioids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health, St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
- Faculty of Medicine and Health, School of Population Health, University of New South Wales, Sydney, Australia.
- National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
- Maternal and Fetal Medicine, Royal Hospital for Women, Sydney, Australia.
- Faculty of Medicine and Health, Leeder Centre for Health Policy, Economics, and Data, Child Population and Translational Health Research, The University of Sydney, Sydney, Australia.
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
ORCID-Profile: Jonathan Brett, Alys Havard, Krista F Huybrechts
Förderung
- National Health and Medical Research Council
- Centre of Research Excellence in Medications Intelligence
Zitieren
APA
Brett, J., Bruno, C., Varney, B., Havard, A., Shand, A., Huybrechts, K. F., & Zoega, H. (2025). Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study. International Journal of Epidemiology, 54(4). https://doi.org/10.1093/ije/dyaf137
Vancouver
Brett J, Bruno C, Varney B, Havard A, Shand A, Huybrechts KF, et al. Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study. International Journal of Epidemiology. 2025;54(4). doi:10.1093/ije/dyaf137
BibTeX
@article{Brett2025,
author = {Brett, Jonathan and Bruno, Claudia and Varney, Bianca and Havard, Alys and Shand, Antonia and Huybrechts, Krista F and Zoega, Helga},
title = {Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study},
journal = {International Journal of Epidemiology},
year = {2025},
volume = {54},
number = {4},
doi = {10.1093/ije/dyaf137}
}
EUVIMED